Management of the dry eye in Sjogren's syndrome.
D000111:Acetylcysteine / Q000627:therapeutic use; D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D004564:Electrocoagulation; D005100:Expectorants / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D007637:Keratoconjunctivitis / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D008853:Microscopy; D008875:Middle Aged; D009301:Nasolacrimal Duct / Q000601:surgery; D009883:Ophthalmic Solutions; D012859:Sjogren's Syndrome / Q000150:complications*; D013666:Tears
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D005100:Expectorants; D005938:Glucocorticoids; D009883:Ophthalmic Solutions; D000111:Acetylcysteine